LUX-Head & Neck-1 trial with Afatinib Results #hncs16

LUX-Head & Neck-1 trial with Afatinib Results #hncs16

ASTROHN2016

4 years
682 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ezra Cohen, MD of the University of California at San Diego discusses the results of the LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy at ASTRO Head and Neck Symposium 2016.
Up Next Autoplay